MakroCare and ADDS sign exclusive partnership for Safety services
HYDERABAD: MakroCare is one of the fastest growing global CROs and a leader in providing clinical and medical services at the international level. Advanced Drug Development Services (ADDS) is a European CRO into advanced process of drugs and medical devices development, situated in France.
These two companies announced this November the signing of an exclusive partnership agreement for Pharmacovigilance and Drug safety services. This partnership allows both the companies to offer their wide range of Clinical, Medical and Safety services to pharmaceutical, biotechnology, and medical devices companies in key territories -USA/Europe/Asia/Africa.
Both the Companies will operate in key strategic areas of practice in the said regions, allowing each other an opportunity to offer their best and cost effective services to their existing and potential clients, leading to a better business outcome as well as successful development.